Radiopharm Theranostics Limited American Depositary Shares (RADX) — Defensive Interval Ratio
Radiopharm Theranostics Limited American Depositary Shares (RADX) has a Defensive Interval Ratio of 337 days as of June 2026. Defensive assets of $17.45 Million (cash $-, short-term investments $-, receivables $17.45 Million) cover 337 days of daily cash needs of $51.78K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Radiopharm Theranostics Limited American Depositary Shares Defensive Interval Ratio (2022–2026)
This chart shows how Radiopharm Theranostics Limited American Depositary Shares's Defensive Interval Ratio has evolved across 5 annual periods from 2022 to 2026. As of June 2026, the ratio stands at 337 days, meaning defensive assets of $17.45 Million can fund 337 days of operations without new revenue. For the complete balance sheet picture, see Radiopharm Theranostics Limited American total assets.
Annual Defensive Interval Ratio for Radiopharm Theranostics Limited American Depositary Shares (2022–2026)
The table below presents the year-by-year Defensive Interval Ratio for Radiopharm Theranostics Limited American Depositary Shares from 2022 to 2026, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Radiopharm Theranostics Limited American short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2026 | 337 days | $17.45 Million | $51.78K/day | $- | $- | ▲ +83 days |
| 2025 | 254 days | $10.40 Million | $40.91K/day | $- | $- | ▲ +234 days |
| 2024 | 21 days | $987.41K | $48.15K/day | $- | $- | ▼ -103 days |
| 2023 | 123 days | $4.47 Million | $36.24K/day | $- | $- | ▲ +121 days |
| 2022 | 3 days | $56.48K | $21.59K/day | $- | $- | — |